InsidersTradesSigma
Browse the detailed record of transactions filed by Cermak Elizabeth, Director. Insider active across 1 companies, notably Clarus Therapeutics Holdings, Inc.. In total, 3 disclosures have been published. The latest transaction was disclosed on 7 June 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations
Elizabeth Cermak is a Board Member at Clarus Therapeutics Holdings, Inc. She plays a key role in the company's governance and strategic decision-making. Her experience enriches discussions within the board.